|
Malignant Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
Overall and cancer specific survival (OS, CSS) were estimated using Kaplan-Meier method and differences were compared using log-rank test.
|
31179077 |
2019 |
|
Primary malignant neoplasm
|
0.050 |
Biomarker
|
group |
BEFREE |
Overall and cancer specific survival (OS, CSS) were estimated using Kaplan-Meier method and differences were compared using log-rank test.
|
31179077 |
2019 |
|
Malignant Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
Two-year cancer-specific (2y-CSS) and 2-year overall survival (2y-OS) related to histopathological tumor stage of RARC patients calculated by Kaplan-Meier method were compared to ORC patients using log-rank test.
|
30045033 |
2018 |
|
Malignant Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
The pooled results indicated that higher Gal-9 expression in cancer tissue associated with an improved CSS (HR=0.48, 95% CI 0.39-0.58).
|
29428936 |
2018 |
|
Primary malignant neoplasm
|
0.050 |
Biomarker
|
group |
BEFREE |
Two-year cancer-specific (2y-CSS) and 2-year overall survival (2y-OS) related to histopathological tumor stage of RARC patients calculated by Kaplan-Meier method were compared to ORC patients using log-rank test.
|
30045033 |
2018 |
|
Primary malignant neoplasm
|
0.050 |
AlteredExpression
|
group |
BEFREE |
The pooled results indicated that higher Gal-9 expression in cancer tissue associated with an improved CSS (HR=0.48, 95% CI 0.39-0.58).
|
29428936 |
2018 |
|
Malignant Neoplasms
|
0.050 |
GeneticVariation
|
group |
BEFREE |
Eight cancer hallmark-based gene signatures (30 genes each) were identified and used to construct CSS sets for determining prognosis.
|
26502222 |
2016 |
|
Primary malignant neoplasm
|
0.050 |
GeneticVariation
|
group |
BEFREE |
Eight cancer hallmark-based gene signatures (30 genes each) were identified and used to construct CSS sets for determining prognosis.
|
26502222 |
2016 |
|
Malignant Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
The expression of Dicer in colorectal carcinoma shows a strong association with poor survival (cancer specific survival=CSS, p<0,001) as well as with reduced progression free survival (PFS, p<0,001).
|
21345667 |
2011 |
|
Primary malignant neoplasm
|
0.050 |
Biomarker
|
group |
BEFREE |
The expression of Dicer in colorectal carcinoma shows a strong association with poor survival (cancer specific survival=CSS, p<0,001) as well as with reduced progression free survival (PFS, p<0,001).
|
21345667 |
2011 |
|
Colorectal Carcinoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Moreover, low CMAS gene expression correlated with reduced recurrence-free survival in a human colorectal cancer cohort, supporting the clinical relevance of our work.
|
30578646 |
2019 |
|
Colorectal Carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
The presence of LVI was the only independent and statistically significant prognostic variable for CSS in our cohort of pTNM stage I CRCs.
|
30018674 |
2018 |
|
Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
Two-year cancer-specific (2y-CSS) and 2-year overall survival (2y-OS) related to histopathological tumor stage of RARC patients calculated by Kaplan-Meier method were compared to ORC patients using log-rank test.
|
30045033 |
2018 |
|
Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
<b>Results:</b> In the SEER cohort, CSS differences increased as the tumor enlarged until a threshold tumor size group (tumor measuring 7-8 cm, <i>P</i> < 0.001) was reached, in which node positivity showed the maximum negative effect on CSS; multivariate Cox analyses showed that tumors measuring 7-8 cm presented a significant lower risk of cancer-specific mortality compared with those measuring 2-4 cm [hazard ratio (HR) = 1.087; 95% confidence interval (CI) = 1.014-1.165, <i>P</i> = 0.018].
|
30619744 |
2018 |
|
Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
In conclusion, primary tumor LN status was a strong predictor of CSS after palliative resection of metastatic colorectal cancer.
|
28430643 |
2017 |
|
Colorectal Carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
The CSS sets were validated in 11 independent cohorts of 767 patients with stage II CRC who did not receive adjuvant chemotherapy.
|
26502222 |
2016 |
|
Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
BAP1 mutations tend to occur in Fuhrman grade III-IV tumors (p = 0.052) and are associated with worse CSS (p = 0.01).
|
23036577 |
2013 |
|
Colorectal Carcinoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
The expression of Dicer in colorectal carcinoma shows a strong association with poor survival (cancer specific survival=CSS, p<0,001) as well as with reduced progression free survival (PFS, p<0,001).
|
21345667 |
2011 |
|
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
We found that in ccRCC, high interleukin (IL)-23 expression was significantly associated with poor survival in both TCGA (overall survival [OS] hazard ratio [HR]=2.04, cancer-specific survival [CSS] HR=2.95; all p<0.001) and Shanghai (OS HR=2.07, CSS HR=3.92; all p<0.001) cohorts.
|
30293904 |
2019 |
|
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Results showed that high Ki-67 expression in RCC was associated with poor OS (HR = 1.95, 95% CI: 1.44-2.64), CSS (HR = 1.67, 95% CI: 1.47-1.89), and DFS (HR = 2.56, 95% CI: 1.79-3.67).
|
28287186 |
2017 |
|
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Most mutations of chromatin modulators discovered in ccRCC are loss of function, associated with advanced stage, grade, and possibly worse CSS.
|
23036577 |
2013 |
|
Vasculitis
|
0.020 |
Biomarker
|
disease |
BEFREE |
As described in the results, CSS were the most frequent cases reported, belonging to the Vasculitis category.
|
31837440 |
2020 |
|
Intellectual Disability
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Before the present study, no links between mutations in CMAS and incidences of human ID had been reported.
|
31495922 |
2020 |
|
Neoplasm Metastasis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Surgery was not associated with increased OS and CSS for UTEC with celiac or supraclavicular node metastasis but was favored as a predictor of better OS and CSS for LTEC with celiac or supraclavicular node metastasis.
|
31293066 |
2019 |
|
Coffin-Siris syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
Interestingly, the two resulting CPs, [Ag(Py-4-CSS)] <sub>n</sub> 1 and [Ag<sub>2</sub>(Py-4-CSS)(Py-4-CSSS)] <sub>n</sub> 2 (Py-4-CSS = pyridine-4-dithiocarboxylate; Py-4-CSSS = pyridine-4-perthiocarboxylate), show disparate structures due to the varied coordination mode of the pyridine group.
|
31038933 |
2019 |